Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Nijhawan Pardeep, Chairman & CEO. Officer active across 1 company, notably Edesa Biotech, Inc.. Cumulatively, 34 disclosures have been published. Breakdown: 12 buys · 0 sell. Total volume traded: €101k. Activity tracked since 9 March 2022. The latest transaction was disclosed on 1 June 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
5,000 shares@ US$1.91980.051% mcap17.3% of flowCommon SharesSEC:0001654954-22-007684:0
Ideal exit: 21 Feb 2023 (T+270)
25 of 34 declarations
About Nijhawan Pardeep
Pardeep Nijhawan is the Chief Executive Officer of Edesa Biotech, Inc. He leads the company with a focus on innovation and the development of biopharmaceutical treatments. Edesa Biotech, Inc. is a biotechnology company that focuses on therapeutic solutions for autoimmune diseases.